eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]
Other and unspecified postprocedural disorders of eye and adnexa
DOID EFO Endpoint Browser PheWeb
H7_POSTOPEYENAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
65 |
4. Check minimum number of eventsNone |
65 |
5. Include endpointsNone |
65 |
6. Filter based on genotype QC (FinnGen only) |
65 |
Control definitions (FinnGen only)
- Control exclude
- H7_EYEPOSTOP
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified postprocedural disorders of eye and adnexa
based on the number of shared cases.
Similar with more cases:
- Postprocedural disorders of eye and adnexa, not elsewhere classified
- Other disorders of eye and adnexa
- Diseases of the eye and adnexa
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 541 | 282 | 257 |
| Only index persons | 456 | 238 | 218 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 71.21 | 72.30 | 70.00 |
| Only index persons | 69.97 | 70.56 | 69.33 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 65 | 38 | 27 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 71.54 | 71.86 | 71.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 53
- Matched controls
- 530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H59.9
ICD-10 Finland
Postprocedural disorder of eye and adnexa, unspecified
+∞
34.1
29
*
H59.8
ICD-10 Finland
Other postprocedural disorders of eye and adnexa
+∞
27.5
24
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
11.6
14.1
31
57
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
9.3
12.5
40
131
CKD60
NOMESCO Finland
Anterior vitrectomy
37.8
9.9
12
*
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
40.2
8.4
10
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
5.7
8.3
34
127
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
22.6
8.0
11
6
WX140
NOMESCO Finland
Parabulbar anesthesy
13.9
7.8
13
12
WX100
NOMESCO Finland
Conjunctival surface anesthesia
7.0
7.6
20
42
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
24.1
7.4
10
5
H33.0
ICD-10 Finland
Retinal detachment with retinal break
13.7
7.2
12
11
S01ED51
ATC
timolol, combinations; ophthalmic
10.1
7.2
14
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019225) pH of Specimen
20
45
5.98
9.11
3.4
3.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
21
66
4.22
6.26
4.2
5.6
%
30.6
31.9
0.19
11
36
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
20
5.73
4.95
1.4
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
40
247
2.61
3.43
4.8
5.6
mmol/l
1.2
1.2
2.22
32
223
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
43
280
2.58
3.23
4.9
6.0
mmol/l
1.2
1.2
2.17
38
226
(3013512) EKG study
30
169
2.44
3.03
4.6
4.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
22
4.57
3.01
1.3
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
121
2.24
2.24
1.8
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
172
0.39
1.97
3.8
3.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
35
240
1.99
1.96
4.1
6.0
%
25.1
26.0
0.16
30
223
(36660697) Celiac disease serology panel - Serum
9
34
2.91
1.95
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
43
321
2.00
1.84
2.3
2.8
u/l
56.9
54.1
0.04
34
293
(3044640) Blood type and Crossmatch panel - Blood
27
174
1.94
1.76
1.7
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
19
3.37
1.70
2.8
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
35
250
1.87
1.65
2.9
3.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
35
253
1.83
1.56
4.0
5.5
e9/l
0.6
0.6
0.65
28
224
(3013115) Eosinophils [#/volume] in Blood
36
263
1.83
1.55
4.1
5.7
e9/l
0.2
0.2
1.26
28
236
(42870588) Differential panel, method unspecified - Blood
27
181
1.84
1.53
3.3
5.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
35
255
1.81
1.51
4.1
5.6
e9/l
0.0
0.0
0.02
28
226
(3009343) pH of Capillary blood
7
29
2.58
1.43
2.6
2.5
—
7.4
—
0
6
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
29
2.58
1.43
3.6
6.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
16
92
1.98
1.41
1.6
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
8
154
0.45
1.37
5.4
7.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
35
261
1.74
1.35
4.1
5.5
e9/l
1.8
1.8
0.13
29
237
(3022621) pH of Urine by Test strip
8
38
2.26
1.23
3.3
2.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
48
398
1.79
1.21
4.4
4.4
mm/h
12.5
13.0
0.11
43
353
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
58
515
2.17
1.15
12.7
16.6
mg/l
21.7
24.2
0.27
51
423
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
32
241
1.65
1.13
2.1
2.0
pmol/l
75.1
97.2
1.64
12
109
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
32
2.33
1.12
1.3
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
59
531
2.20
1.07
13.5
16.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
28
0.00
1.00
0.0
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
17
241
0.60
0.97
5.5
11.7
e9/l
0.0
0.0
—
9
206
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
54
478
1.77
0.90
5.0
4.7
mu/l
2.1
2.0
0.36
47
420
(3012516) Albumin [Mass/volume] in Urine
22
160
1.57
0.86
4.5
3.0
mg/l
74.0
80.9
0.04
13
96
(3019060) Gas panel - Arterial blood
8
47
1.80
0.84
1.5
2.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
9
141
0.58
0.82
1.4
1.7
mmol/l
0.8
1.3
—
9
115
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
75
1.74
0.82
4.5
7.6
—
—
—
0
0
(3020891) Body temperature
0
25
0.00
0.81
0.0
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
16
222
0.63
0.81
2.7
4.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
37
306
1.49
0.78
5.2
10.2
e9/l
4.7
4.5
0.11
30
276
(3009542) Hematocrit [Volume Fraction] of Blood
50
444
1.55
0.71
13.7
18.0
%
38.5
39.7
0.23
21
287
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
29
1.78
0.65
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
20
0.00
0.61
0.0
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
20
0.00
0.61
0.0
2.2
—
0.3
—
0
12
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
21
0.00
0.61
0.0
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
30
248
1.39
0.59
3.7
3.9
ng/l
51.1
55.4
0.06
18
180
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
38
1.64
0.56
1.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
53
485
1.50
0.55
13.1
16.1
ml/min/173m2
72.1
76.1
0.57
37
398
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
54
496
1.52
0.55
5.0
5.2
mmol/l
6.0
6.0
0.20
44
444
(3007853) Bacteria identified in Skin by Aerobe culture
9
63
1.50
0.55
1.4
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
9
63
1.50
0.55
1.2
1.3
—
292.5
—
0
16
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
64
1.47
0.54
1.6
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
22
175
1.39
0.53
4.7
3.8
mg/mmol
25.2
11.6
0.27
12
105
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
56
523
1.51
0.49
4.5
5.4
mmol/l
2.7
2.6
0.17
45
467
(40761535) Cells panel - Urine sediment
7
49
1.48
0.48
3.1
3.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
24
197
1.35
0.47
2.1
3.7
mmol/l
2.4
2.3
2.13
14
164
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
44
395
1.35
0.47
3.5
3.7
pmol/l
15.7
15.0
1.05
36
342
(3041096) Erythrocytes [Presence] in Urine by Automated
12
160
0.69
0.47
2.6
4.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
181
0.71
0.46
3.6
3.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
52
480
1.42
0.46
3.8
4.3
mmol/l
1.2
1.2
0.12
42
428
(3021960) Folate [Moles/volume] in Serum or Plasma
19
151
1.36
0.45
1.8
1.5
nmol/l
20.1
23.1
0.29
12
123
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
16
0.00
0.41
0.0
3.2
—
16.0
—
0
7
(3012501) Base excess in Blood by calculation
0
16
0.00
0.41
0.0
4.6
—
2.1
—
0
11
(3013290) Carbon dioxide [Partial pressure] in Blood
0
16
0.00
0.41
0.0
4.6
—
5.1
—
0
16
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
16
0.00
0.41
0.0
4.6
—
7.8
—
0
16
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.8
—
56.9
—
0
18
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
18
0.00
0.40
0.0
2.3
—
125.5
—
0
12
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
75
1.39
0.32
1.2
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
57
543
1.40
0.32
16.9
19.1
umol/l
80.9
80.6
0.03
57
543
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
53
500
1.32
0.31
4.3
4.9
mmol/l
4.6
4.5
0.19
44
453
(36304419) Bacteria [Presence] in Urine
12
150
0.75
0.31
3.4
3.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
18
151
1.27
0.29
2.4
4.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
65
1.26
0.28
1.5
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
34
372
0.82
0.28
2.9
4.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
23
201
1.22
0.26
2.6
3.2
ng/l
1541.6
1781.1
0.13
18
166
(40768797) Stomach Pathology biopsy report
6
80
0.72
0.26
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
37
1.38
0.24
1.4
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
19
217
0.82
0.23
2.5
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
17
196
0.82
0.22
3.6
4.1
e6/l
13.2
69.3
2.41
12
144
(4010399)
5
41
1.24
0.22
2.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
11
0.00
0.21
0.0
2.7
—
88.4
—
0
11
(3024928) Oxygen saturation in Venous blood
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
13
0.00
0.21
0.0
2.6
—
1.3
—
0
13
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
0
14
0.00
0.20
0.0
1.4
—
295.8
—
0
7
(1616796) Gas panel - Central venous blood
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
52
498
1.22
0.19
4.5
4.9
mmol/l
1.6
1.5
0.66
43
446
(3003694) ABO and Rh group [Type] in Blood
11
131
0.81
0.19
1.4
1.4
—
—
—
0
0
(3012544) pH of Venous blood
7
57
1.26
0.19
2.3
3.3
—
—
—
0
0
(3002256) Pathology report gross observation
7
58
1.23
0.19
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
62
1.14
0.18
1.0
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
8
71
1.14
0.17
4.5
4.6
mmol/l
1.1
1.1
—
8
62
(3042936) Bacteria identified in Isolate by Culture
7
89
0.76
0.15
1.3
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
39
371
1.13
0.13
5.9
4.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
51
493
1.16
0.13
6.5
6.6
mmol/mol
39.3
40.9
0.78
42
450
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
5
48
1.05
0.09
1.0
2.1
g/l
0.2
0.2
—
5
43
(40760892) CBC W Ordered Manual Differential panel - Blood
10
113
0.86
0.09
3.6
4.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
60
0.82
0.08
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
19
178
1.10
0.06
4.7
5.2
ug/l
1.8
2.0
0.07
19
154
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
28
268
1.08
0.06
2.8
2.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
19
201
0.92
0.05
3.7
3.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
11
120
0.90
0.05
3.0
3.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
143
1.06
0.02
4.3
4.4
%
21.5
22.2
—
6
69
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
2.8
—
30.2
—
0
6
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
0.9
—
0
5
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
4.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
4.9
—
0
7
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.6
—
60.1
—
0
7
(3039443) Prostate specific Ag panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
52
0.96
0.00
1.6
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(4268621)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
2.8
—
0
7
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_POSTOPEYENAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_POSTOPEYENAS | 1.186 [0.87, 1.61] | 0.277 |
| Birth year | 0.998 [0.99, 1.01] | 0.592 |
During the follow-up period (1.1.1998 — 31.12.2019), 77 out of 221 females with H7_POSTOPEYENAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_POSTOPEYENAS | 1.221 [0.89, 1.68] | 0.222 |
| Birth year | 0.987 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 207 males with H7_POSTOPEYENAS died.
Mortality risk
Mortality risk for people of age
years, who have H7_POSTOPEYENAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.158% | 0.267% |
| 5 | 0.729% | 1.541% |
| 10 | 1.938% | 3.612% |
| 15 | 3.787% | 6.642% |
| 20 | 6.666% | 11.455% |
Relationships between endpoints
↥Index endpoint: H7_POSTOPEYENAS – Other and unspecified postprocedural disorders of eye and adnexa
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data